What is Docetaxel-carboplatin-trastuzumab (TCH)?

Category: Prescription Drugs


See also: Carboplatin Docetaxel Trastuzumab

Docetaxel-carboplatin-trastuzumab, also known as TCH, is a regimen that may be used for the treatment of breast cancer. It contains the anticancer agents docetaxel (Taxotere®), carboplatin, and trastuzumab (Herceptin®).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Docetaxel-carboplatin-trastuzumab (TCH)

Side effect Patients
Diarrhea 1
Fatigue 1
Fever/chills 1


Based on patients currently taking Docetaxel-carboplatin-trastuzumab (TCH)

Dosage Patients
weekly 1


Currently taking Docetaxel-carboplatin-trastuzumab (TCH)

Duration Patients
1 - 2 years 1

What people switch to and from

Patients stopped taking Docetaxel-carboplatin-trastuzumab (TCH) and switched to:

Treatment Patients
Cetuximab (Erbitux) 1
Last updated:
There are no evaluations for Docetaxel-carboplatin-trastuzumab (TCH).